CD40-CD40L信号通路与急性冠脉综合征相关性研究进展
Research Progress on Relationship between CD40-CD40L Signal Pathway and Acute Coronary Syndrome
DOI: 10.12677/ACM.2020.1011376, PDF,   
作者: 李 燕, 胡扬扬, 陈 鹏：昆明医科大学药学院暨云南省天然药物药理重点实验室，云南 昆明
关键词: 急性冠脉综合征；CD40-CD40L信号通路；研究进展；Acute Coronary Syndrome； CD40-CD40L Signal Pathway； Research Progress
摘要: CD40及其免疫调节配体CD40L是一对互补跨膜糖蛋白，分别属于神经生长因子受体(NGFR)/肿瘤坏死因子受体(TNF-R)超家族和肿瘤坏死因子(TNF)超家族成员，参与许多疾病的发生发展过程。研究发现，CD40-CD40L通路不仅与免疫性疾病(自身免疫性疾病和免疫缺陷病)的发展进程密切相关，同时还介导炎症反应，几乎贯穿急性冠状动脉综合征(acute coronary syndrome, ACS)全过程。现就CD40-CD40L通路与急性冠脉综合征的相关性做一简要概述，以期进一步为探讨CD40-CD40L通路与心血管疾病的预防、治疗提供理论依据。
Abstract: CD40 and its immunoregulatory ligand (CD40L) are a pair of complementary transmembrane glycoproteins belonging to the nerve growth factor receptor (NGFR)/tumor necrosis factor receptor (TNF-R) superfamily and tumor necrosis factor (TNF) superfamily respectively and participate in the occurrence and development of many diseases. It has been found that CD40-CD40L signal pathway is not only closely related to the development of immune diseases (autoimmune and immune deficiency diseases), but also mediates inflammatory response, almost throughout the whole process of acute coronary syndrome (ACS). In this paper, the interactions between CD40- CD40L pathway and acute coronary syndrome were briefly summarized, to provide more theoretical basis for CD40-CD40L signal pathway and prevention and treatment of cardiovascular diseases.
文章引用：李燕, 胡扬扬, 陈鹏. CD40-CD40L信号通路与急性冠脉综合征相关性研究进展[J]. 临床医学进展, 2020, 10(11): 2493-2498. https://doi.org/10.12677/ACM.2020.1011376

参考文献

[1] 徐谭, 刘如平, 袁俊强, 等. 急性冠状动脉综合征患者经皮冠状动脉介入术后平均血小板容积对近期预后的影响[J]. 中国动脉硬化杂志, 2020, 28(7): 599-603.
[2] 王顺楷, 方志敏, 刘顺民, 等. 循环microRNA-126在急性冠脉综合征患者中的表达差异[J]. 世界最新医学信息文摘, 2019, 19(91): 27+30.
[3] 方子寒, 谢盈彧, 张军平. 急性冠状动脉综合征中医诊治概述[J]. 中华中医药学刊, 2019, 37(8): 1852-1855.
[4] Moreno, P.R., Purushothaman, K.R., Fuster, V., et al. (2002) Intimomedial Interface Damage and Adventitial Inflammation Is Increased beneath Disrupted Atherosclerosis in the Aorta: Implications for Plaque Vulnerability. Circulation, 105, 2504-2511. [Google Scholar] [CrossRef] 
[5] Lairez, O. and Hyafil, F. (2020) A Clinical Role of PET in Atherosclerosis and Vulnerable Plaques? Seminars in Nuclear Medicine, 50, 311-318. [Google Scholar] [CrossRef] [PubMed]
[6] 徐成斌. 急性冠脉综合征的病理与病理生理学[J]. 中国医刊, 2001, 36(11): 7-9.
[7] Cholette, J.M., Blumberg, N., Phipps, R.P., et al. (2008) Developmental Changes in Soluble CD40 Ligand. The Journal of Pediatrics, 152, 50-54. [Google Scholar] [CrossRef] [PubMed]
[8] Geldart, T. and Illidge, T. (2005) Anti-CD40 Monoclonal Antibody. Leukemia & Lymphoma, 46, 1105-1113. [Google Scholar] [CrossRef] [PubMed]
[9] 杜振兰. CD40-CD40L共刺激途径在体液免疫和细胞免疫中的作用[J]. 细胞与分子免疫学杂志, 2012, 28(12): 1341-1343.
[10] Volker, H., Joseph, R.S., Michael, G., et al. (1998) CD40 Ligand on Activated Platelets Triggers an Inflammatory Reaction of Endothelial Cells. Nature, 391, 591-594. [Google Scholar] [CrossRef] [PubMed]
[11] Danese, S., Sans, M. and Fiocchi, C. (2004) The CD40/CD40L Costimulatory Pathway in Inflammatory Bowel Disease. Gut, 53, 1035-1043. [Google Scholar] [CrossRef] [PubMed]
[12] 吴辉, 吴伟, 卿立金. CD40/CD40L信号通路与易损斑块关系及中医药干预策略[J]. 中国医师协会中西医结合医师大会, 2011, 23(12): 373-375.
[13] Liu, Y.F., Yu, H.M., Zhang, Y., et al. (2008) TLRs Are Important Inflammatory Factors in Atherosclerosis and May Be a Therapeutic Target. Medical Hypotheses, 70, 314-316. [Google Scholar] [CrossRef] [PubMed]
[14] Schönbeck, U., Mach, F., Bonnefoy, J.Y., et al. (1997) Ligation of CD40 Activates Interleukin 1beta-Converting Enzyme (Caspase-1) Activity in Vascular Smooth Muscle and Endothelial Cells and Promotes Elaboration of Active Interleukin 1beta. Journal of Biological Chemistry, 272, 19569-19574. [Google Scholar] [CrossRef] [PubMed]
[15] Van, J.M., Da, M.P., Mol, A., et al. (2008) Transendothelial Migration Drives Dissociation of Plateletmonocyte Complexes. Thrombosis and Haemostasis, 100, 271-279. [Google Scholar] [CrossRef] 
[16] Van, L.M., Gijbels, M.J., et al. (2008) Accumulation of Myeloperoxidase-Positive Neutrophils in Atherosclerotic Lesions in LDLR-/-mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 84-89. [Google Scholar] [CrossRef] 
[17] Soehnlein, O., Zernecke, A., Eriksson, E.E., et al. (2008) Neutrophil Secretion Products Pave the Way for Inflammatory Monocytes. Blood, 112, 1461-1471. [Google Scholar] [CrossRef] [PubMed]
[18] Erbel, C., Sato, K., Meyer, F.B., et al. (2007) Functional Profile of Activated Dendritic Cells in Unstable Atherosclerotic Plaque. Basic Research in Cardiology, 102, 123-132. [Google Scholar] [CrossRef] [PubMed]
[19] 朱星. 散结通脉方对动脉粥样硬化大鼠CD40/CD40L信号通路干预的实验研究[D]: [博士学位论文]. 长春: 长春中医药大学, 2019, 204(3): 1246-1352.
[20] 朱丹, 赵旭颖, 李海啸, 等. 急性脑梗死患者颈动脉斑块与基质金属蛋白酶、血清白介素及多肽生长因子的关系研究[J]. 现代生物医学进展, 2019, 19(18): 3465-3469+545.
[21] 杨雪娜, 熊咏民. 基质金属蛋白酶在骨关节疾病中的研究进展[J]. 国外医学(医学地理分册), 2019, 40(4): 470-474.
[22] Heider, P., Pelisek, J., Poppert, H., et al. (2009) Evaluation of Serum Matrix Metalloproteinases as Biomarkers for Detection of Neurological Symptoms in Carotid Artery Disease. Vascular and Endovascular Surgery, 43, 551-560. [Google Scholar] [CrossRef] [PubMed]
[23] 李江, 赵水平, 彭道泉, 等. 冠心病患者血清sCD40L和MMP-9的变化及相关性[J]. 中南大学学报(医学版), 2004, 103(5): 517-520.
[24] 刘全生, 张雯凌. 可溶性CD40L水平对急性脑梗死患者颈动脉粥样硬化斑块稳定性的影响[J]. 中国实用神经疾病杂志, 2016, 19(7): 12-13.
[25] Lee, J.J. (2007) Matrix Metalloproteinases: Influence on Smooth Muscle Cells and Atherosclerotic Plaque Stability. Expert Review of Cardiovascular Therapy, 5, 265-282. [Google Scholar] [CrossRef] [PubMed]
[26] 刘智敏. 基质金属蛋白酶的结构、功能和调节[J]. 生物医学工程学杂志, 2015(4): 680-683.
[27] Duran, C.L., Howell, D.W., Dave, J.M., et al. (2017) Molecular Regulation of Sprouting Angiogenesis. Comprehensive Physiology, 8, 153-235. [Google Scholar] [CrossRef] [PubMed]
[28] Asghar, F., Ali, S., Houman, K., et al. (2019) Therapeutic Targeting of Angiogenesis Molecular Pathways in Angiogenesis-Dependent Diseases. Biomedicine & Pharmacotherapy, 110, 775-785. [Google Scholar] [CrossRef] [PubMed]
[29] Ribatti, D. (2014) The Discovery of Angiogenic Growth Factors: The Contribution of Italian Scientists. Vascular Cell, 6, 162-170. [Google Scholar] [CrossRef] 
[30] Leroyer, A.S., Pierre-Emmanuel, R., Jean-Sébastien, S., et al. (2008) CD40 Ligand+ Microparticles from Human Atherosclerotic Plaques Stimulate Endothelial Proliferation and Angiogenesis a Potential Mechanism for Intraplaque Neovascularization. Journal of the American College of Cardiology, 52, 1302-1311. [Google Scholar] [CrossRef] [PubMed]
[31] Simonini, A., Moscucci, M., Mulle, D.W.M., et al. (2000) IL-8 Is an Angiogenic Factor in Human Coronary Atherectomy Tissue. Circulation, 101, 1519-1526. [Google Scholar] [CrossRef] 

为你推荐